Partner
Daniel Jacobs
Founder & Managing Partner, Pathway Bioventures
- Firm
- Pathway Bioventures
- Title
- Founder & Managing Partner
- Role
- Managing partner
- Known as
- Investor
Record updated 18 September 2026
About
Daniel founded Pathway Bioventures in 2018 to accelerate the growth of groundbreaking early-stage life sciences companies. He leads Pathway’s operations and investment activities including the identification of new opportunities, diligence, and portfolio company support. A cancer researcher by training, Daniel has expertise in cancer epidemiology, genomics, and RNA therapeutics, having authored or co-authored over 25 peer-reviewed scientific articles and book chapters. He has served as a Board Observer for Modifi Bio (acquired by Merck), Biograph55, and miRecule and as an Entrepreneur-in-Residence at Yale Ventures. Daniel holds an MPH and PhD from Yale University and received post-doctoral training at Baylor College of Medicine.
Background
- Education
- Daniel holds an MPH and PhD from Yale University and received post-doctoral training at Baylor College of Medicine.Source (opens in a new tab)
Is this you? Remove my profile